Copits Bryan A, Vernon Claire G, Sakai Ryuichi, Swanson Geoffrey T
Department of Molecular Pharmacology and Biological Chemistry, Northwestern University Feinberg School of Medicine, Chicago, IL, 60611, USA.
Graduate School of Fisheries Sciences, Hokkaido University, Hakodate, 041-8611, Japan.
J Physiol. 2014 May 15;592(10):2079-96. doi: 10.1113/jphysiol.2013.269597. Epub 2014 Mar 10.
AMPA and kainate receptors are glutamate-gated ion channels whose function is known to be altered by a variety of plant oligosaccharide-binding proteins, or lectins, but the physiological relevance of this activity has been uncertain because no lectins with analogous allosteric modulatory effects have been identified in animals. We report here that members of the prototype galectin family, which are β-galactoside-binding lectins, exhibit subunit-specific allosteric modulation of desensitization of recombinant homomeric and heteromeric AMPA and kainate receptors. Galectin modulation of GluK2 kainate receptors was dependent upon complex oligosaccharide processing of N-glycosylation sites in the amino-terminal domain and downstream linker region. The sensitivity of GluA4 AMPA receptors to human galectin-1 could be enhanced by supplementation of culture media with uridine and N-acetylglucosamine (GlcNAc), precursors for the hexosamine pathway that supplies UDP-GlcNAc for synthesis of complex oligosaccharides. Neuronal kainate receptors in dorsal root ganglia were sensitive to galectin modulation, whereas AMPA receptors in cultured hippocampal neurons were insensitive, which could be a reflection of differential N-glycan processing or receptor subunit selectivity. Because glycan content of integral proteins can be modified dynamically, we postulate that physiological or pathological conditions in the CNS could arise in which galectins alter excitatory neurotransmission or neuronal excitability through their actions on AMPA or kainate receptors.
AMPA受体和海人藻酸受体是谷氨酸门控离子通道,已知其功能会被多种植物寡糖结合蛋白(即凝集素)改变,但由于在动物中尚未鉴定出具有类似变构调节作用的凝集素,这种活性的生理相关性一直不确定。我们在此报告,原型半乳糖凝集素家族的成员是β-半乳糖苷结合凝集素,它们对重组同聚和异聚AMPA受体和海人藻酸受体的脱敏表现出亚基特异性变构调节。半乳糖凝集素对GluK2海人藻酸受体的调节依赖于氨基末端结构域和下游连接区中N-糖基化位点的复杂寡糖加工。通过在培养基中添加尿苷和N-乙酰葡糖胺(GlcNAc),即己糖胺途径的前体,可为合成复杂寡糖提供UDP-GlcNAc,可增强GluA4 AMPA受体对人半乳糖凝集素-1的敏感性。背根神经节中的神经元海人藻酸受体对半乳糖凝集素调节敏感,而培养的海马神经元中的AMPA受体不敏感,这可能反映了不同的N-聚糖加工或受体亚基选择性。由于整合蛋白的聚糖含量可动态修饰,我们推测中枢神经系统中的生理或病理状况可能会出现,其中半乳糖凝集素通过其对AMPA或海人藻酸受体的作用改变兴奋性神经传递或神经元兴奋性。